Rare neurodegenerative diseases (RNDs) include a group of progressive, debilitating disorders such as Huntington’s disease, amyotrophic lateral sclerosis (ALS), and frontotemporal dementia. These conditions are characterized by the gradual loss of neuron function, leading to severe disability and mortality.

Market Overview

The rare neurodegenerative disease treatment market is gaining traction as advancements in biotechnology and genomics open new therapeutic pathways. Despite small patient populations, the unmet medical need and orphan drug incentives are driving pharmaceutical innovation.

Market Drivers

Growing genetic research: Advances in genomics and molecular biology have led to targeted drug development.

Welcome to the group! You can connect with other members, get updates and share photos.